Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Nova Trial Stream

 

Mehiläinen buys in Germany, gets ‘passport’ to invest

Finland's largest for-profit healthcare operator by revenue Mehiläinen has made its first acquisition in Germany. The acquired hospital, Dalberg Klinik, is the ticket to further investments in the country's outpatient sector, HBI hears from Janne-Olli Järvenpää, Mehiläinen's CEO.

New Cera Care tech to diagnose flu in minutes

UK homecare group Cera Care is expanding its network with 15 digital healthcare hubs across the UK to deliver telehealth and medication services. The tech-savvy operator will further launch a digital flu tracker and treatment system. HBI talks with Igal Aciman, Chief Commercial Officer at Cera to find out more.

Thailand open for vaxxed medical tourists

Thailand has re-opened for medical tourists without quarantine as the country seeks to revive its ailing medical tourism sector. We look at the impact that the 18-month ban has had on the country's big hospital groups Bumrungrad International Hospital and Bangkok Dusit Medical Services (BDMS).

Final stage of German adult care reform due in 2023

Since 2017, reform in Germany's social security law has given disabled people more money and greater control over how they spent it. The final stage, due next year, will increase the number of people eligible for benefits that help them integrate into society. Adult care providers tell HBI that it has been difficult for them to adapt.

Is Eurofins’ share price drop an overreaction?

The share price of global lab group Eurofins is down 18% since a high at the end of September. Is it all an overreaction? A raised revenue guidance - but not EBITDA - points to falling margins for the group. 

Cyberattack hits Fullerton’s vendor partner

A cyberattack on the Agape Connecting People network, a vendor that helps Singapore-based healthcare major Fullerton Health to manage patient appointments and bookings, has resulted in a data leak of Fullerton's patients’ personal information.

Lab share prices drop from Covid created peaks

In this week’s infographic we take a closer look at the lab market stocks, mapping the percentage change from March 2020 to date for six of the largest players in the sector globally -  Medicover, Sonic Healthcare, Synlab, Dian Diagnostics, Diagnosticos da America (DASA), and Grupo Fleury. What does it show?

Will Babylon succeed?

Ali Parsa, the founder of Babylon Health, is now a paper billionaire with control of a business with an enterprise value of $3.6bn with an additional $575m in gross proceeds, following its merger with special acquisition vehicle Alkuri. The nearly 90% of the SPAC shareholders who chose to sell before the shares started trading may be kicking themselves - the shares peaked at $16 on October 26, though as of the time of writing are sitting at $10.82, up from the initial opening price of 10$ on October 22.

Find Us